📰 Product Testing News
Page 37 - Product Testing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Product Testing. Real-time updates on events, politics, business and more.
February 20, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
February 20, 2021
MEXICO CITY — Mexico says it will get its first shipment of the Chinese Coronavac vaccine Saturday and by Monday will receive its first lot of the Russian Sputnik V
February 20, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation. Delta Verde Laboratory Positioned for Dynamic Growth in the Cannabis Industry February 19, 2021 GMT PHOENIX--(BUSINESS WIRE)--Feb 19, 2021-- Delta Verde Laboratory, an Arizona based analytical testing lab, is positioned for dynamic and accelerated growth in the cannabis industry and has recently been granted additional compliance testing approvals in areas of both chemistry and microbiology. ADVERTISEM...
February 19, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Precision Announces 3-Year Pre-clinical Study Results Showing Long-term Durability and Safety ... Precision BiosciencesFebruary 19, 2021 GMT DURHAM, N.C., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage biotechnology company, today announced the publication of a paper in Molecular Therapy describing three-year follow-up data showing long-term stable reduc...
February 19, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.
February 19, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation. Dr. Reddy’s Initiates Process for Emergency Use Authorization of Sputnik V February 19, 2021 GMT HYDERABAD, India--(BUSINESS WIRE)--Feb 19, 2021-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has initiated the process with the Drugs Controller General of India (D...
February 19, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Longeveron Inc. Announces the Appointment of Prominent Biotech, Capital Markets and Corporate ... LongeveronFebruary 18, 2021 GMT MIAMI, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced the appointments of D...
February 19, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Pharvaris Presents Pharmacodynamic Activity of Oral PHA121, Under Development for the Treatment ... Pharvaris N.V.February 19, 2021 GMT ZUG, Switzerland, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies, including novel, small molecule bradykinin-B2-receptor antago...
February 19, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Athenex Announces U.S. Launch of Klisyri® and Licensing of Additional Territories for Tirbanibulin Athenex, Inc.February 18, 2021 GMT Athenex Announces Licensing of Additional Territories for the Development and Commercialization of Tirbanibulin in Japan and South Korea. PharmaEssentia Expands Tirbanibulin Partnership by Adding Japan and South Korea to Already Licensed Territories of Taiwan, Singapor...
February 19, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Clene Nanomedicine to Present Updated Interim Data from Phase 2 Multiple Sclerosis Programs at ... Clene Inc.February 19, 2021 GMT SALT LAKE CITY, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced that it will present updated interim...